Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-02-24

Clinical Trial Update: Role of the Gut Sweet Taste Receptor in the Secretion of Satiation Peptides [Phase 1]

View source ↗

Summary

Phase 1 clinical trial at University Hospital Basel explored the role of the gut sweet taste receptor in the secretion of satiation peptides and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Taste Disorder, Secondary, Sweet | Phase 1 | Status: COMPLETED